Average Co-Inventor Count = 5.88
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Minnesota (14 from 2,308 patents)
2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (11 from 3,539 patents)
3. Intima Bioscience, Inc. (11 from 13 patents)
4. B-mogen Biotechnologies, Inc. (4 from 4 patents)
5. Rd Systems (2 from 6 patents)
6. Other (1 from 832,843 patents)
21 patents:
1. 12281327 - Lymphohematopoietic engineering using CAS9 base editors
2. 12270050 - Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using
3. 12097220 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
4. 12037611 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
5. 11925664 - Intracellular genomic transplant and methods of therapy
6. 11903966 - Intracellular genomic transplant and methods of therapy
7. 11760983 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
8. 11642374 - Intracellular genomic transplant and methods of therapy
9. 11642375 - Intracellular genomic transplant and methods of therapy
10. 11583556 - Modified cells and methods of therapy
11. 11278570 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
12. 11266692 - Intracellular genomic transplant and methods of therapy
13. 11162084 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
14. 11154574 - Tumor infiltrating lymphocytes and methods of therapy
15. 11147837 - Modified cells and methods of therapy